openPR Logo
Press release

The Biological Drugs market to witness a stellar performance, reach US$ 287,139.7 by 2020

09-23-2022 10:46 AM CET | Health & Medicine

Press release from: Persistence Market Research

According to a new market report published by Persistence Market Research "Global Market Study on Biological Drugs: North America to Witness Highest Growth By 2020", the global biological drugs market was valued at US$ 161,056.5 Mn in 2014 and is expected to grow at a CAGR of 10.1% from 2014 to 2020, to reach US$ 287,139.7 Mn by 2020.

Biological drugs are typically derived from living cells and are used in the prevention and treatment of various diseases such as cancer, blood disorders, auto-immune diseases, and other medical disorders. Biological drugs have more complex structures compared to that of conventional drugs.
Globally, the biological drugs market is witnessing significant growth due to the increasing prevalence of chronic diseases and growing geriatric population. In addition, health and awareness initiatives by various government associations are also supporting the growth of the biological drugs market. However, high costs of biological drugs and patent expiry of blockbuster drugs impede the growth of the biological drugs market. Moreover, risks of adverse effects associated with biologic injectable drugs also inhibit the growth of the market.

Request For Free Sample Report of Biological Drugs @ https://www.persistencemarketresearch.com/samples/2883

The global biological drugs market is anticipated to grow from an estimated US$ 161,056.5 Mn in 2014 to US$ 287,139.7 Mn by 2020 at a CAGR 10.1% during the forecast period.

North America dominates the global biological drugs market. This is due to increasing use of biological drugs in the treatment of diseases such as cancer, diabetes, and other chronic diseases in the region. In addition, several clinics in the region are focusing on biological drugs for the treatment of various diseases.
The biological drugs market in Europe is growing due to increasing aging population in the region. For instance, according to a UN report, elderly people accounted for 23.2% of the total population in Germany in 2000, and the number is expected to reach 33.2% by 2025. Aging can lead to certain disorders such as age-related macular degeneration and glaucoma, which require effective biological drugs for their treatment.

Low manufacturing costs in Asia are attracting biopharmaceutical companies to invest in the region, supporting the growth of the biological drugs market. Moreover, governments of some Asian countries are also supporting the growth of the biological drugs market by providing funds to life sciences research institutes and biotech companies for the construction of R&D and manufacturing facilities.

Buy The Complete Report to read the analysed strategies adopted by the top vendors either to retain or gain market share@ https://www.persistencemarketresearch.com/checkout/2883

Novartis AG, Pfizer Inc., GlaxoSmithKline plc., and Merck & Co., Inc. are some of the leading players in the global biological drugs market. Other major players in the market include Abbott Laboratories, Baxter International Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Biogen Idec, and Amgen Inc.

The global biological drugs market is segmented as follows:

By therapeutic protein
• Enbrel
• Lantus
• Neulasta
• Avonex
• NovoLog
• Rebif
• Fall down
• Aranesp
• Epogen
• Levemir
• Victoza
• Betaseron
• Neupogen
• Eylea
By monoclonal antibody (mAb)
• Humira
• Remicade
• Rituxan
• I discovered
• Herceptin
• Lucentis
• By vaccine
• Prenvar 13
• Gardasil
• Fluzone
• Varivax
• Cervarix
By geography
• North America
• Europe
• Asia
• Rest of the World (RoW)

For more information about this report visit@ https://www.persistencemarketresearch.com/market-research/global-biological-drugs-market.asp

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Biological Drugs market to witness a stellar performance, reach US$ 287,139.7 by 2020 here

News-ID: 2746983 • Views:

More Releases from Persistence Market Research

Agricultural Microbial Market to Reach US$ 17.47 Bn by 2032: Growth Driven by Sustainable Farming Practices and Crop Yield Enhancement
Agricultural Microbial Market to Reach US$ 17.47 Bn by 2032: Growth Driven by Su …
The agricultural microbial market is gaining remarkable traction as global farming practices shift toward sustainability, efficiency, and soil health improvement. Microbials-comprising beneficial bacteria, fungi, viruses, and protozoa-play a vital role in promoting plant growth, enhancing nutrient uptake, and protecting crops from diseases. With the world facing mounting pressure to increase agricultural productivity while minimizing environmental impact, microbial-based products are emerging as essential tools for modern agriculture. According to the latest study
Pine-derived Chemicals Market to Reach US$ 8.7 Bn by 2032, Driven by Rising Demand for Sustainable Bio-based Products
Pine-derived Chemicals Market to Reach US$ 8.7 Bn by 2032, Driven by Rising Dema …
The global pine-derived chemicals market is witnessing steady growth as industries increasingly shift toward bio-based, renewable, and sustainable raw materials. Derived from pine trees, these chemicals-such as rosin, turpentine, and tall oil-are used in a variety of industrial and consumer applications, ranging from adhesives and coatings to food, pharmaceuticals, and personal care products. With growing awareness about environmental sustainability and the circular economy, pine-derived chemicals are gaining prominence as natural
Bio-succinic Acid Market to Reach US$ 415.3 Mn by 2032: Growth Driven by Rising Demand for Sustainable Chemicals
Bio-succinic Acid Market to Reach US$ 415.3 Mn by 2032: Growth Driven by Rising …
The bio-succinic acid market is rapidly emerging as a key component of the global bio-based chemical industry, owing to its versatile applications and sustainable production process. Bio-succinic acid, derived from renewable feedstocks such as sugar, corn, and agricultural waste, serves as a sustainable alternative to petrochemical-based succinic acid. Its eco-friendly nature, combined with rising concerns over carbon emissions and fossil fuel depletion, has made it increasingly popular across multiple industries. According
Polybutylene Adipate Terephthalate Market Valued at US$ 2,819.7 Mn by 2032, Driven by Rising Demand for Compostable Plastics
Polybutylene Adipate Terephthalate Market Valued at US$ 2,819.7 Mn by 2032, Driv …
The global Polybutylene Adipate Terephthalate (PBAT) market is experiencing robust expansion, primarily driven by the escalating demand for sustainable and compostable alternatives to traditional petroleum-based plastics. According to the latest study by Persistence Market Research, the PBAT market size is poised to reach US$ 1,522.8 Mn by 2025, and with increasing environmental concerns and stringent government regulations against plastic waste, it is projected to grow at a CAGR of 9.2%,

All 5 Releases


More Releases for Biological

Biological Control Market Projected to Witness Massive Growth - Koppert Biologic …
Biological Control Market Snapshot The Biological Control Market is projected to reach USD 9.7 billion by 2032, growing at a CAGR of 9.4% from 2025 to 2032. Coherent Market Insights proudly presents its latest Biological Control Market Research Report, delivering a detailed examination of the U.S. Biological Control Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,
Biological and Chemical Indicators Market - Beyond Measure: Biological and Chemi …
Newark, New Castle, USA: The "Biological and Chemical Indicators Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological and Chemical Indicators Market: https://www.growthplusreports.com/report/biological-and-chemical-indicators-market/8887 This latest report researches the
Biological APIs Market - Biological APIs: The Driving Force Behind Cutting-Edge …
Newark, New Castle, USA: The "Biological APIs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Biological APIs Market: https://www.growthplusreports.com/report/biological-apis-market/8769 This latest report researches the industry structure, sales, revenue,
Human Immunoglobulin for Intravenous Injection Market demand and future scope wi …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global Human Immunoglobulin for Intravenous Injection. On the basis of historic growth analysis and current scenario of Human Immunoglobulin for Intravenous Injection place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from
Global Biological safety testing Market | Global Biological safety testing Indus …
Biologics are termed as those product that attained from living organism and feature a differentiate set of properties. The biologics want extreme safety from contamination thus biological safety testing is incorporate timely to make sure its safety quality and non-contamination of vaccines & biopharmaceuticals, along with comply with the bound rules applicable on it. A number of the foremost biological tests are sterility testing, bioburden testing, residual host contaminant detection
Meningococcal Infections Vaccine Market Insights, Forecast to 2025 : Sanofi-Past …
Researchmoz added Most up-to-date research on "Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025" to its huge collection of research reports. This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions. This research report categorizes the global Meningococcal Infections Vaccine market